相关实验视频

Updated: Sep 10, 2025

Isolation and Functional Assessment of Human Breast Cancer Stem Cells from Cell and Tissue Samples

Isolation and Functional Assessment of Human Breast Cancer Stem Cells from Cell and Tissue Samples

Published on: October 2, 2020

针对乳腺癌干细胞的蛋白标记依赖药物发现

Ashley V Huang¹, Yali Kong¹, Kan Wang¹

¹Department of Biomedical and Translational Sciences, Macon & Joan Brock Virginia Health Sciences at Old Dominion University, Norfolk, VA 23507, USA.

International journal of molecular sciences

|August 28, 2025

概括

乳腺癌干细胞 (BCSC) 导致治疗耐药性和复发. 使用标记物,途径,人工智能和时间疗法准BCSC对于改善乳腺癌结果至关重要.

科学领域:

癌症学
癌症干细胞生物学

背景情况:

乳腺癌是全球主要的癌症.
乳腺癌干细胞 (BCSC) 常常是治疗耐药性和复发的原因.
BCSC具有自我更新和分化能力,促进瘤的再生和转移.

研究的目的:

审查针对BCSCs的依赖标记的策略.
讨论开发抗BCSC药物的挑战.
探索人工智能驱动的药物发现和时间治疗等新方法.

主要方法:

对BCSC标记物 (例如CD44,ALDH1) 和途径 (Wnt,Notch,Hedgehog) 的文献综述.
分析针对BCSC的当前治疗策略.
在药物发现中探索新兴技术.

主要成果:

关键标志物和途径对于BCSC监管至关重要.
在开发有效的抗BCSC疗法方面存在重大挑战.
人工智能和时间治疗为未来的研究提供了有前途的途径.

结论:

克服针对乳腺癌的障碍对于改善乳腺癌治疗至关重要.
整合人工智能和时间疗法等新方法可能会提高治疗效果.
需要进一步的研究才能将这些策略转化为临床实践.

关键词:

其他疾病一个 DCLK-1 乳腺癌干细胞生物节律药物发现下射频节奏

更多相关视频

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells

Published on: January 18, 2017

Obtaining Cancer Stem Cell Spheres from Gynecological and Breast Cancer Tumors

Obtaining Cancer Stem Cell Spheres from Gynecological and Breast Cancer Tumors

Published on: March 1, 2020

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Cancer Stem Cells and Tumor Maintenance

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...